For: | Tonini V, Zanni M. Early diagnosis of pancreatic cancer: What strategies to avoid a foretold catastrophe. World J Gastroenterol 2022; 28(31): 4235-4248 [PMID: 36159004 DOI: 10.3748/wjg.v28.i31.4235] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v28/i31/4235.htm |
Number | Citing Articles |
1 |
Cheng Wei, Yi-Chen Li, Hong-Tao Jin, De-Feng Li, Li-Sheng Wang, Jun Yao. Early detection of pancreatic cancer in patients with recurrent pancreatitis: A case report. World Journal of Clinical Cases 2024; 12(19): 3936-3941 doi: 10.12998/wjcc.v12.i19.3936
|
2 |
Hao Cheng. Innovative Computing Vol 1 - Emerging Topics in Artificial Intelligence. Lecture Notes in Electrical Engineering 2023; 1044: 396 doi: 10.1007/978-981-99-2092-1_50
|
3 |
Kanchan Yadav, Manish Sharma, A. Deepak, K Mayuri, Deepika Arora, Pankaj Singh. Early Detection of Pancreatic Cancer Using Ensemble Learning with Medical Imaging. 2023 10th IEEE Uttar Pradesh Section International Conference on Electrical, Electronics and Computer Engineering (UPCON) 2023; : 1846 doi: 10.1109/UPCON59197.2023.10434602
|
4 |
Hans Scherübl. Früherkennung des sporadischen Pankreasadenokarzinoms. TumorDiagnostik & Therapie 2024; 45(03): 178 doi: 10.1055/a-2267-3513
|
5 |
Chao Liu, Jiang Du, Jianwei Zheng, Ruizhe Zhang, Jialin Zhu, Bofan Xing, Lin Dong, Qianqian Zhou, Xiaofeng Yao, Song Gao, Yu Wang, Yu Ren, Xuan Zhou. The role of BHLHE40 in clinical features and prognosis value of PDAC by comprehensive analysis and in vitro validation. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1151321
|
6 |
Songbai Liu, Peng Liu, Xiaobin Fei, Changhao Zhu, Junyi Hou, Xing Wang, Yaozhen Pan. Analysis and validation of the potential of the MYO1E gene in pancreatic adenocarcinoma based on a bioinformatics approach. Oncology Letters 2023; 26(1) doi: 10.3892/ol.2023.13871
|
7 |
Rose G. McHardy, Georgios Antoniou, Justin J. A. Conn, Matthew J. Baker, David S. Palmer. Augmentation of FTIR spectral datasets using Wasserstein generative adversarial networks for cancer liquid biopsies. The Analyst 2023; 148(16): 3860 doi: 10.1039/D3AN00669G
|
8 |
Noha Elkady, Walaa Elgendy, Mohamed T. Badr, Hayam Aiad, Manar Samara, Nahla M. Badr. Evaluation of the diagnostic utility of NCOA3, Maspin and VHL protein expression in pancreatic ductal adenocarcinoma: An immunohistochemical study. Annals of Diagnostic Pathology 2024; 73: 152356 doi: 10.1016/j.anndiagpath.2024.152356
|
9 |
Yusuke Seiki, Kenji Ikezawa, Ko Watsuji, Makiko Urabe, Yugo Kai, Ryoji Takada, Takuo Yamai, Kaori Mukai, Tasuku Nakabori, Hiroyuki Uehara, Miki Ishibashi, Kazuyoshi Ohkawa. Zinc supplementation for dysgeusia in patients with unresectable pancreatic cancer. International Journal of Clinical Oncology 2024; 29(8): 1173 doi: 10.1007/s10147-024-02544-w
|
10 |
Paulina Koziol-Bohatkiewicz, Danuta Liberda-Matyja, Tomasz P. Wrobel. Fast cancer imaging in pancreatic biopsies using infrared imaging. The Analyst 2024; 149(6): 1799 doi: 10.1039/D3AN01555F
|
11 |
Kjetil Søreide, Warsan Ismail, Marcus Roalsø, Jacob Ghotbi, Claudia Zaharia. Early Diagnosis of Pancreatic Cancer: Clinical Premonitions, Timely Precursor Detection and Increased Curative-Intent Surgery. Cancer Control 2023; 30 doi: 10.1177/10732748231154711
|
12 |
Jia-Jun Zhong, Yan-Qing Ye. Construction and validation of a nomogram model for predicting early death in patients with metastatic pancreatic adenocarcinoma based on SEER database. World Chinese Journal of Digestology 2023; 31(14): 577 doi: 10.11569/wcjd.v31.i14.577
|
13 |
Caitlin A. McIntyre, Adrien Grimont, Jiwoon Park, Yinuo Meng, Whitney J. Sisso, Kenneth Seier, Gun Ho Jang, Henry Walch, Victoria G. Aveson, David J. Falvo, William B. Fall, Christopher W. Chan, Andrew Wenger, Brett L. Ecker, Alessandra Pulvirenti, Rebecca Gelfer, Maria Paz Zafra, Nikolaus Schultz, Wungki Park, Eileen M. O’Reilly, Shauna L. Houlihan, Alicia Alonso, Erika Hissong, George M. Church, Christopher E. Mason, Despina Siolas, Faiyaz Notta, Mithat Gonen, Lukas E. Dow, William R. Jarnagin, Rohit Chandwani. Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer. Cancer Cell 2024; 42(9): 1614 doi: 10.1016/j.ccell.2024.08.002
|
14 |
Xin Zhang, Licheng Wei, Jiangguo Li, Yuexia Deng, Wei Xu, Dongkui Chen, Xing Li. Influence of myosteatosis on survival of patients with pancreatic cancer: A systematic review and meta-analysis. iScience 2024; 27(12): 111343 doi: 10.1016/j.isci.2024.111343
|
15 |
Hans Scherübl. Früherkennung des sporadischen Pankreasadenokarzinoms. Zeitschrift für Gastroenterologie 2024; 62(03): 412 doi: 10.1055/a-2114-9847
|
16 |
He Jiang, Guo-Tai Wang, Zheng Wang, Qing-Yong Ma, Zhen-Hua Ma. Resveratrol inhibits pancreatic cancer proliferation and metastasis by depleting senescent tumor-associated fibroblasts. World Journal of Gastrointestinal Oncology 2024; 16(9): 3980-3993 doi: 10.4251/wjgo.v16.i9.3980
|
17 |
Lingxiao Wang, Lingyun Wang, Xiao Sun, Lili Fu, Xinlei Wang, Xiaoyan Wang, Lingxin Chen, Yan Huang. Detection of uridine diphosphate glucuronosyltransferase 1A1 for pancreatic cancer imaging and treatment via a “turn-on” fluorescent probe. The Analyst 2024; 149(10): 2877 doi: 10.1039/D4AN00035H
|